Safety and efficacy of programming a high number of antitachycardia pacing attempts for fast ventricular tachycardia: A prospective study

Europace

Volumn 14, Issue 10, 2012, Pages 1457-1464

  Martins, Raphaël P ^a   Blangy, Hugues ^a   Muresan, Lucian ^a   Freysz, Luc ^a   Groben, Laurent ^a   Zinzius, Pierre Yves ^a   Schwartz, Jérôme ^a   Sellal, Jean Marc ^a   Aliot, Etienne ^a   Sadoul, Nicolas ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Antitachycardia pacing; Implantable cardioverter defibrillators; Ventricular tachyarrhythmias

Indexed keywords

ADULT; AGED; ANTITACHYCARDIA PACING; ARTICLE; CORONARY ARTERY DISEASE; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEART PACING; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; PRIORITY JOURNAL; PROSPECTIVE STUDY;

AGED; CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHY, DILATED; CORONARY ARTERY DISEASE; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; MIDDLE AGED; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME;

EID: 84866923126     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eus107     Document Type: Article

References (25)

1. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006;8:746-837.
2. Sweeney MO, Wathen MS, Volosin K, Abdalla I, DeGroot PJ, Otterness MF, et al. Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial. Circulation 2005;111:2898-905.
3. Wathen MS, Sweeney MO, DeGroot PJ, Stark AJ, Koehler JL, Chisner MB, et al. Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease. Circulation 2001;104: 796-801.
4. Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO, et al. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation 2004;110: 2591-6.
5. GrimmW, Plachta E, Maisch B. Antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with prophylactic cardioverter- defibrillator therapy. Pacing Clin Electrophysiol 2006;29:759-64.
6. Gulizia MM, Piraino L, Scherillo M, Puntrello C, Vasco C, Scianaro MC, et al. A randomized study to compare ramp versus burst antitachycardia pacing therapies to treat fast ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators: the PITAGORA ICD trial. Circ Arrhythm Electrophysiol 2009;2: 146-53.
7. Jimenez-Candil J, Arenal A, Garcia-Alberola A, Ortiz M, del Castillo S, Fernandez-Portales J, et al. Fast ventricular tachycardias in patients with implantable cardioverter-defibrillators: efficacy and safety of antitachycardia pacing. A prospective and randomized study. J Am Coll Cardiol 2005;45:460-1.
8. Saeed M, Neason CG, Razavi M, Chandiramani S, Alonso J, Natarajan S, et al. Programming antitachycardia pacing for primary prevention in patients with implantable cardioverter defibrillators: results from the PROVE Trial. J Cardiovasc Electrophysiol 2010;21:1349-54.
9. Santini M, Lunati M, Defaye P, Mermi J, Proclemer A, del Castillo-Arroys S, et al. Prospective multicenter randomized trial of fast ventricular tachycardia termination by prolonged versus conventional anti-tachyarrhythmia burst pacing in implantable cardioverter-defibrillator patients-Atp DeliVery for pAiNless ICD thErapy (ADVANCE-D) Trial results. J Interv Card Electrophysiol 2010;27:127-35.
10. Gasparini M, Anselme F, Clementy J, Santini M, Martinez-Ferrer J, De Santo T, et al. BIVentricular versus right ventricular antitachycardia pacing to terminate ventricular tachyarrhythmias in patients receiving cardiac resynchronization therapy: the ADVANCE CRT-D Trial. Am Heart J 2010;159:1116-23 e2.
11. Priori SG, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P, et al. Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J 2001;22:1374-450.
12. Sharma V, DeGroot PJ, Wathen MS. Incidence and characteristics of type-2 breaks in response to antitachycardia pacing therapy in implantable cardioverter defibrillator patients. J Cardiovasc Electrophysiol 2003;14:1156-62.
13. Chauvin M, Frank R, Le Heuzey JY, Barnay C, Cazeau S, Djiane P, et al. [Recommendations on the implantation and surveillance of implantable defibrillators]. Arch Mal Coeur Vaiss 2004;97:915-9.
14. Sweeney MO. Antitachycardia pacing for ventricular tachycardia using implantable cardioverter defibrillators. Pacing Clin Electrophysiol 2004;27:1292-305.
15. Barold SS, Herweg B. Making sense of the new ICD algorithms for the treatment of fast ventricular tachycardia. Pacing Clin Electrophysiol 2009;32:149-52.
16. Schoels W, Steinhaus D, Johnson WB, O'Hara G, Schwab JO, Jenniskens I, et al. Optimizing implantable cardioverter-defibrillator treatment of rapid ventricular tachycardia: antitachycardia pacing therapy during charging. Heart Rhythm 2007; 4:879-85.
17. Lo R, Al-Ahmad A, Hsia H, Zei PC, Wang PJ. Optimal programming of ICDs for prevention of appropriate and inappropriate shocks. Curr Treat Options Cardiovasc Med 2008;10:408-16.
18. Schwab JO. Optimizing ICD programming for shock reduction. Fundam Clin Pharmacol 2010;24:653-9.
19. Wazni O, Wilkoff BL. Strategic choices to reduce implantable cardioverterdefibrillator- related morbidity. Nat Rev Cardiol 2010;7:376-83.
20. Fries R, Heisel A, Kalweit G, Jung J, Schieffer H. Antitachycardia pacing in patients with implantable cardioverter defibrillators: how many attempts are useful? Pacing Clin Electrophysiol 1997;20(1 Pt 2):198-202.
21. Cygankiewicz I, Gillespie J, Zareba W, Brown MW, Goldenberg I, Klein H, et al. Predictors of long-term mortality in Multicenter Automatic Defibrillator Implantation Trial II (MADIT II) patients with implantable cardioverter- defibrillators. Heart Rhythm 2009;6:468-73.
22. Duray GZ, Schmitt J, Richter S, Israel CW, Hohnloser SH. Arrhythmic death in implantable cardioverter defibrillator patients: a long-term study over a 10 year implantation period. Europace 2009;11:1462-8.
23. Greenberg H, Case RB, Moss AJ, Brown MW, Carroll ER, Andrews ML. Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II). J Am Coll Cardiol 2004;43:1459-65.
24. Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW, et al. Strategic programming of detection and therapy parameters in implantable cardioverterdefibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. J Am Coll Cardiol 2008;52:541-50.
25. Volosin KJ, Exner DV, Wathen MS, Sherfesee L, Scinicariello AP, Gillberg JM. Combining shock reduction strategies to enhance ICD therapy: a role for computer modeling. J Cardiovasc Electrophysiol 2011;22:280-9.